Pricing
Login
Home
Charts
Search
Watchlist
Products

Sun Pharmaceutical Industries Ltd

SUNPHARMA
₹1,884.90-0.79%20 Nov 2026
Reports
Pharma Formulations

Sun Pharmaceutical Industries Ltd

SUNPHARMA
₹1,884.90
-0.79%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹4,52,251Cr
Close
Close Price
₹1,884.90
Industry
Industry
Pharma Formulations
PE
Price To Earnings
41.25
PS
Price To Sales
7.34
Revenue
Revenue
₹61,631Cr
Rev Gr TTM
Revenue Growth TTM
12.13%
PAT Gr TTM
PAT Growth TTM
4.94%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
12,38111,98312,65313,29113,67512,95913,85114,47815,52114,61215,30016,199
Growth YoY
Revenue Growth YoY%
10.19.66.09.010.58.19.58.913.512.810.511.9
Expenses
ExpensesCr
8,9048,9489,0459,3529,6669,2439,5509,95110,57210,65810,88211,455
Operating Profit
Operating ProfitCr
3,4773,0353,6083,9394,0093,7164,3024,5274,9483,9544,4184,744
OPM
OPM%
28.125.328.529.629.328.731.131.331.927.128.929.3
Other Income
Other IncomeCr
180504533354149251-35447089459520-752
Interest Expense
Interest ExpenseCr
35746269524975100788610075
Depreciation
DepreciationCr
622650655626631664701730732775739758
PBT
PBTCr
3,0002,8163,4243,5983,4763,2543,1734,1684,2273,5514,0993,159
Tax
TaxCr
4321495525675591,0948701,0318268281,1881,158
PAT
PATCr
2,5682,6672,8713,0312,9182,1612,3033,1373,4012,7242,9112,002
Growth YoY
PAT Growth YoY%
17.432.242.626.213.6-19.0-19.83.516.626.126.4-36.2
NPM
NPM%
20.722.322.722.821.316.716.621.721.918.619.012.4
EPS
EPS₹
10.511.111.812.712.19.09.513.014.011.312.18.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
12,38111,98312,65313,29113,67512,95913,85114,47815,52114,61215,30016,199
Growth YoY
Revenue Growth YoY%
10.19.66.09.010.58.19.58.913.512.810.511.9
Expenses
ExpensesCr
8,9048,9489,0459,3529,6669,2439,5509,95110,57210,65810,88211,455
Operating Profit
Operating ProfitCr
3,4773,0353,6083,9394,0093,7164,3024,5274,9483,9544,4184,744
OPM
OPM%
28.125.328.529.629.328.731.131.331.927.128.929.3
Other Income
Other IncomeCr
180504533354149251-35447089459520-752
Interest Expense
Interest ExpenseCr
35746269524975100788610075
Depreciation
DepreciationCr
622650655626631664701730732775739758
PBT
PBTCr
3,0002,8163,4243,5983,4763,2543,1734,1684,2273,5514,0993,159
Tax
TaxCr
4321495525675591,0948701,0318268281,1881,158
PAT
PATCr
2,5682,6672,8713,0312,9182,1612,3033,1373,4012,7242,9112,002
Growth YoY
PAT Growth YoY%
17.432.242.626.213.6-19.0-19.83.516.626.126.4-36.2
NPM
NPM%
20.722.322.722.821.316.716.621.721.918.619.012.4
EPS
EPS₹
10.511.111.812.712.19.09.513.014.011.312.18.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
28,48731,57826,48929,06632,83833,49838,65443,88648,49752,57858,46261,631
Growth
Revenue Growth%
3.810.8-16.19.713.02.015.413.510.58.411.212.1
Expenses
ExpensesCr
20,32921,48920,88122,75825,86325,03028,41132,23935,51037,49241,97143,567
Operating Profit
Operating ProfitCr
8,15810,0895,6086,3086,9748,46810,24411,64712,98715,08616,49118,064
OPM
OPM%
28.631.921.221.721.225.326.526.526.828.728.229.3
Other Income
Other IncomeCr
-27623-112-189391-3,447-3,4914638961,4731,904316
Interest Expense
Interest ExpenseCr
523400518555303141127172238231339339
Depreciation
DepreciationCr
1,0381,2651,5001,7532,0532,0802,1442,5292,5572,5752,9383,005
PBT
PBTCr
6,5719,0483,4793,8105,0102,7994,4819,40811,08813,75215,11915,037
Tax
TaxCr
9141,2129116018235151,0768481,4392,7723,5543,999
PAT
PATCr
5,6577,8362,5683,2094,1872,2853,4068,5619,64810,98011,56511,037
Growth
PAT Growth%
3.138.5-67.225.030.5-45.449.1151.412.713.85.34.9
NPM
NPM%
19.924.89.711.012.86.88.819.519.920.919.817.9
EPS
EPS₹
18.929.08.711.115.712.113.635.339.945.647.845.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
28,48731,57826,48929,06632,83833,49838,65443,88648,49752,57858,46261,631
Growth
Revenue Growth%
3.810.8-16.19.713.02.015.413.510.58.411.212.1
Expenses
ExpensesCr
20,32921,48920,88122,75825,86325,03028,41132,23935,51037,49241,97143,567
Operating Profit
Operating ProfitCr
8,15810,0895,6086,3086,9748,46810,24411,64712,98715,08616,49118,064
OPM
OPM%
28.631.921.221.721.225.326.526.526.828.728.229.3
Other Income
Other IncomeCr
-27623-112-189391-3,447-3,4914638961,4731,904316
Interest Expense
Interest ExpenseCr
523400518555303141127172238231339339
Depreciation
DepreciationCr
1,0381,2651,5001,7532,0532,0802,1442,5292,5572,5752,9383,005
PBT
PBTCr
6,5719,0483,4793,8105,0102,7994,4819,40811,08813,75215,11915,037
Tax
TaxCr
9141,2129116018235151,0768481,4392,7723,5543,999
PAT
PATCr
5,6577,8362,5683,2094,1872,2853,4068,5619,64810,98011,56511,037
Growth
PAT Growth%
3.138.5-67.225.030.5-45.449.1151.412.713.85.34.9
NPM
NPM%
19.924.89.711.012.86.88.819.519.920.919.817.9
EPS
EPS₹
18.929.08.711.115.712.113.635.339.945.647.845.7
Sales CAGR
1 Year11%
3 Years10%
5 Years12%
TTM12%
EBITDA CAGR
1 Year9%
3 Years12%
5 Years14%
TTM9%
PAT CAGR
1 Year5%
3 Years11%
5 Years38%
TTM5%
Avg. ROCE
1 Year18%
3 Years18%
5 Years16%
TTM17%
CFO / EBITDA
1 Year75%
3 Years87%
5 Years79%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
241240240240240240240240240240240240
Reserves
ReservesCr
32,74136,40038,07441,16945,02546,22347,77155,75563,42771,97883,33089,040
Current Liabilities
Current LiabilitiesCr
13,14417,88719,86417,34015,70616,14617,20819,90616,98418,19422,62223,592
Non Current Liabilities
Non Current LiabilitiesCr
5,3193,0932,4542,6323,4212,0411,5331,5221,3901,4202,2831,683
Total Liabilities
Total LiabilitiesCr
55,53061,41064,51664,69468,25267,66769,80880,74485,50092,1011,08,7851,14,838
Current Assets
Current AssetsCr
29,94132,95431,63631,06931,65430,44234,86539,86243,43352,59463,86069,267
Non Current Assets
Non Current AssetsCr
25,58928,45732,88033,62536,59837,22534,94340,88242,06739,50744,92545,572
Total Assets
Total AssetsCr
55,53061,41064,51664,69468,25267,66769,80880,74485,50092,1011,08,7851,14,838
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
241240240240240240240240240240240240
Reserves
ReservesCr
32,74136,40038,07441,16945,02546,22347,77155,75563,42771,97883,33089,040
Current Liabilities
Current LiabilitiesCr
13,14417,88719,86417,34015,70616,14617,20819,90616,98418,19422,62223,592
Non Current Liabilities
Non Current LiabilitiesCr
5,3193,0932,4542,6323,4212,0411,5331,5221,3901,4202,2831,683
Total Liabilities
Total LiabilitiesCr
55,53061,41064,51664,69468,25267,66769,80880,74485,50092,1011,08,7851,14,838
Current Assets
Current AssetsCr
29,94132,95431,63631,06931,65430,44234,86539,86243,43352,59463,86069,267
Non Current Assets
Non Current AssetsCr
25,58928,45732,88033,62536,59837,22534,94340,88242,06739,50744,92545,572
Total Assets
Total AssetsCr
55,53061,41064,51664,69468,25267,66769,80880,74485,50092,1011,08,7851,14,838

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
6,6867,0823,9072,1966,5556,1708,9854,95912,13514,07212,419
Investing Cash Flow
Investing Cash FlowCr
-4,372-4,222-3,371-681-2,589536-5,725-7,944-690-5,306-11,344
Financing Cash Flow
Financing Cash FlowCr
-1,889-2,285-1,539-2,731-5,715-5,980-5,1932,376-6,710-7,906-2,513
Net Cash Flow
Net Cash FlowCr
426575-1,003-1,215-1,749726-1,934-6084,735860-1,437
Free Cash Flow
Free Cash FlowCr
3,3533,4922,013-9665,1055,0977,5502,8959,96412,0058,906
CFO To PAT
CFO To PAT%
118.290.4152.268.4156.6270.1263.857.9125.8128.2107.4
CFO To EBITDA
CFO To EBITDA%
82.070.269.734.894.072.987.742.693.493.375.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
6,6867,0823,9072,1966,5556,1708,9854,95912,13514,07212,419
Investing Cash Flow
Investing Cash FlowCr
-4,372-4,222-3,371-681-2,589536-5,725-7,944-690-5,306-11,344
Financing Cash Flow
Financing Cash FlowCr
-1,889-2,285-1,539-2,731-5,715-5,980-5,1932,376-6,710-7,906-2,513
Net Cash Flow
Net Cash FlowCr
426575-1,003-1,215-1,749726-1,934-6084,735860-1,437
Free Cash Flow
Free Cash FlowCr
3,3533,4922,013-9665,1055,0977,5502,8959,96412,0058,906
CFO To PAT
CFO To PAT%
118.290.4152.268.4156.6270.1263.857.9125.8128.2107.4
CFO To EBITDA
CFO To EBITDA%
82.070.269.734.894.072.987.742.693.493.375.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,97,2191,64,9991,18,8621,14,98884,5051,43,3842,19,4912,35,8793,88,8124,16,3934,21,6474,52,251
Price To Earnings
Price To Earnings
43.423.756.843.122.449.467.127.840.638.136.741.3
Price To Sales
Price To Sales
6.95.24.54.02.64.35.75.48.07.97.27.3
Price To Book
Price To Book
6.04.53.12.81.93.14.64.26.15.85.05.1
EV To EBITDA
EV To EBITDA
23.615.721.218.612.316.621.120.429.427.025.124.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
69.566.363.064.364.867.066.569.471.973.874.574.5
OPM
OPM%
28.631.921.221.721.225.326.526.526.828.728.229.3
NPM
NPM%
19.924.89.711.012.86.88.819.519.920.919.817.9
ROCE
ROCE%
17.221.18.38.510.15.89.315.216.918.817.516.7
ROE
ROE%
17.121.46.77.89.34.97.115.315.215.213.812.4
ROA
ROA%
10.212.84.05.06.13.44.910.611.311.910.69.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,97,2191,64,9991,18,8621,14,98884,5051,43,3842,19,4912,35,8793,88,8124,16,3934,21,6474,52,251
Price To Earnings
Price To Earnings
43.423.756.843.122.449.467.127.840.638.136.741.3
Price To Sales
Price To Sales
6.95.24.54.02.64.35.75.48.07.97.27.3
Price To Book
Price To Book
6.04.53.12.81.93.14.64.26.15.85.05.1
EV To EBITDA
EV To EBITDA
23.615.721.218.612.316.621.120.429.427.025.124.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
69.566.363.064.364.867.066.569.471.973.874.574.5
OPM
OPM%
28.631.921.221.721.225.326.526.526.828.728.229.3
NPM
NPM%
19.924.89.711.012.86.88.819.519.920.919.817.9
ROCE
ROCE%
17.221.18.38.510.15.89.315.216.918.817.516.7
ROE
ROE%
17.121.46.77.89.34.97.115.315.215.213.812.4
ROA
ROA%
10.212.84.05.06.13.44.910.611.311.910.69.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr4,52,2511,78,3741,19,7001,16,1191,14,3161,10,0771,03,510
Close PriceClose₹1,884.904,689.501,200.001,390.201,415.002,665.001,799.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.2579.2128.6741.3639.4549.0526.09
Price To SalesPS7.3410.253.943.514.067.162.80
RevenueRevenueCr61,63117,40030,37833,09728,13915,37936,913
Revenue Growth TTMRev Gr TTM%12.1%42.1%24.0%-3.5%-0.7%13.5%13.5%
PAT Growth TTMPAT Gr TTM%4.9%-1.9%-14.6%-51.9%-47.4%27.6%16.5%
Market CapitalizationMkt CapCr4,52,2511,78,3741,19,7001,16,1191,14,3161,10,0771,03,510
Close PriceClose₹1,884.904,689.501,200.001,390.201,415.002,665.001,799.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.2579.2128.6741.3639.4549.0526.09
Price To SalesPS7.3410.253.943.514.067.162.80
RevenueRevenueCr61,63117,40030,37833,09728,13915,37936,913
Revenue Growth TTMRev Gr TTM%12.1%42.1%24.0%-3.5%-0.7%13.5%13.5%
PAT Growth TTMPAT Gr TTM%4.9%-1.9%-14.6%-51.9%-47.4%27.6%16.5%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Annual Reports
Quarterly Reports
Load More
Interviews